Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Advanced Enzyme Technologies buys 70% stake in JC Biotech for Rs50 crore
BackBack

Advanced Enzyme Technologies buys 70% stake in JC Biotech for Rs50 crore

The acquisition will significantly boost market share of Advanced Enzyme Tech in the enzymes space and enable it to enter the biopharmaceutical molecules space

Advanced Enzyme Tech’s share in the Indian enzymes market will rise to about 32-33% after the acquisition from around 25% currently. Photo:BloombergPremium
Advanced Enzyme Tech’s share in the Indian enzymes market will rise to about 32-33% after the acquisition from around 25% currently. Photo:Bloomberg

Mumbai: Advanced Enzyme Technologies Ltd, India’s leading enzyme maker, has entered into definitive agreements to acquire a 70% stake in Hyderabad-based JC Biotech Pvt. Ltd for Rs50 crore.

The acquisition will significantly boost market share of Advanced Enzyme Tech in the enzymes space and enable it to enter the biopharmaceutical molecules space, the company said in a statement.

JC Biotech makes API serratiopeptidase, an anti-inflammatory enzyme, and has a research pipeline of two biopharmaceutical molecules. It also has a fairly advanced technology for the manufacture of algal DHA, an omega-3 fatty acid that finds application in human nutrition.

Advanced Enzyme Tech’s share in the Indian enzymes market will rise to about 32-33% after the acquisition from around 25% currently, managing director C.L. Rathi said, adding that the company will have an 80% share in the API serratiopeptidase market.

The acquisition is likely to add Rs10 crore to the sales of Advanced Enzyme this fiscal and on an annual basis, it may add Rs50-60 crore to revenue and about Rs20 crore to earnings before interest, tax, depreciation and amortization (EBITDA), a company official, who did not wish to be named, said.

The company will finance the acquisition largely through internal accruals and expects to close the transaction by the end of December.

JC Biotech has a production facility in Andhra Pradesh. It earned revenue of Rs39 crore and a net profit of Rs2.5 crore in the ended 31 March, 2016.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 28 Oct 2016, 07:36 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie